{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:54:43Z","timestamp":1790924083368,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09880-4","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:45:15Z","timestamp":1783593915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Auditory neuromodulation-based prescription digital therapeutic for insomnia disorder: study protocol for a randomized controlled trial (SERENE)"],"prefix":"10.1186","volume":"27","author":[{"given":"Kyunghee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonjoong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Won","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Sang","family":"Sunwoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ick","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghwa Jeonglok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"7","key":"9880_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2013.193","volume":"309","author":"DJ Buysse","year":"2013","unstructured":"Buysse DJ. Insomnia. JAMA. 2013;309(7):706\u201316.","journal-title":"JAMA"},{"key":"9880_CR2","volume-title":"Top 100 disease statistics in daily life (in Korean)","author":"Health Insurance Review & Assessment Service","year":"2023","unstructured":"Health Insurance Review & Assessment Service. Top 100 disease statistics in daily life (in Korean). Wonju (Korea): Health Insurance Review & Assessment Service; 2023."},{"issue":"2","key":"9880_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M15-2175","volume":"165","author":"A Qaseem","year":"2016","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125\u201333.","journal-title":"Ann Intern Med"},{"issue":"1","key":"9880_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1037\/a0018715","volume":"51","author":"CM Morin","year":"2010","unstructured":"Morin CM. Chronic insomnia: recent advances and innovations in treatment developments and dissemination. Can Psychol. 2010;51(1):31\u20139.","journal-title":"Can Psychol"},{"issue":"2","key":"9880_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"13","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307\u201349.","journal-title":"J Clin Sleep Med"},{"issue":"9821","key":"9880_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(11)60750-2","volume":"379","author":"CM Morin","year":"2012","unstructured":"Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129\u201341.","journal-title":"Lancet"},{"issue":"12","key":"9880_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/17434440.2020.1852929","volume":"17","author":"CM Morin","year":"2020","unstructured":"Morin CM. Profile of Somryst prescription digital therapeutic for chronic insomnia: overview of safety and efficacy. Expert Rev Med Devices. 2020;17(12):1239\u201348.","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"9880_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s43441-024-00684-9","volume":"58","author":"T Hosono","year":"2024","unstructured":"Hosono T, Niwa Y, Kondoh M. Comparison of product features and clinical trial designs for the DTx products with the indication of insomnia authorized by regulatory authorities. Ther Innov Regul Sci. 2024;58(6):1138\u201347.","journal-title":"Ther Innov Regul Sci"},{"issue":"9","key":"9880_CR9","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.2196\/jmir.4115","volume":"17","author":"C Horsch","year":"2015","unstructured":"Horsch C, Lancee J, Beun RJ, Neerincx MA, Brinkman WP. Adherence to technology-mediated insomnia treatment: a meta-analysis, interviews, and focus groups. J Med Internet Res. 2015;17(9):e214.","journal-title":"J Med Internet Res"},{"issue":"8","key":"9880_CR10","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1016\/S2589-7500(20)30135-7","volume":"2","author":"\u00d8 Vedaa","year":"2020","unstructured":"Vedaa \u00d8, Kallestad H, Scott J, Smith ORF, Pallesen S, Morken G, et al. Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial. Lancet Digit Health. 2020;2(8):e397-406.","journal-title":"Lancet Digit Health"},{"issue":"6","key":"9880_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.sleep.2014.02.004","volume":"15","author":"CM Morin","year":"2014","unstructured":"Morin CM, Beaulieu-Bonneau S, Ivers H, Valli\u00e8res A, Guay B, Savard J, et al. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701\u20137.","journal-title":"Sleep Med"},{"issue":"1","key":"9880_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.smrv.2009.05.002","volume":"14","author":"MH Bonnet","year":"2010","unstructured":"Bonnet MH, Arand DL. Hyperarousal and insomnia: state of the science. Sleep Med Rev. 2010;14(1):9\u201315.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"9880_CR13","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/S0735-1097(00)00595-7","volume":"35","author":"L Bernardi","year":"2000","unstructured":"Bernardi L, Wdowczyk-Szulc J, Valenti C, Castoldi S, Passino C, Spadacini G, et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol. 2000;35(6):1462\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9880_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy032","volume":"41","author":"B Feige","year":"2018","unstructured":"Feige B, Nanovska S, Baglioni C, Bier B, Cabrera L, Diemers S, et al. Insomnia-perchance a dream? Results from a NREM\/REM sleep awakening study in good sleepers and patients with insomnia. Sleep. 2018;41(5):zsy032.","journal-title":"Sleep"},{"issue":"5","key":"9880_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601\u20138.","journal-title":"Sleep"},{"issue":"1","key":"9880_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12874-024-02297-0","volume":"24","author":"Z Qin","year":"2024","unstructured":"Qin Z, Shi J, Gao S, Liu Z, Zhang S, Zhou H, et al. The gap between statistical and clinical significance: time to pay attention to clinical relevance in patient-reported outcome measures of insomnia. BMC Med Res Methodol. 2024;24(1):177.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"9880_CR17","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1185\/03007990903167415","volume":"25","author":"M Yang","year":"2009","unstructured":"Yang M, Morin CM, Schaefer K, Wallenstein GV. Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin. 2009;25(10):2487\u201394.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"9880_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5665\/sleep.1642","volume":"35","author":"CE Carney","year":"2012","unstructured":"Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012;35(2):287\u2013302.","journal-title":"Sleep"},{"issue":"6","key":"9880_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"issue":"10","key":"9880_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Arch Neurol"},{"issue":"9","key":"9880_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"9880_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"10","key":"9880_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"5","key":"9880_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09880-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:22Z","timestamp":1790922742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09880-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9880"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09880-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Kyung Hee University Hospital at Gangdong (KHNMC IRB 2025-11-028; approved November 25, 2025) and by the IRBs of all participating sites.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KK and JH are employees of Bell Therapeutics Inc., the sponsor and developer of BELL-001. JJP is the chief executive officer of Bell Therapeutics Inc. HK and KYJ are shareholders of Bell Therapeutics Inc. All other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"593"}}